Between 1982 and 2011, melanoma incidence doubled—and melanoma continues to cause a majority of skin cancer deaths. As prevalence rises and treatment options expand, many cancer centers are looking to invest in dedicated melanoma programs.
That's why we conducted research on six of these programs, each run by a different organization. Get our key findings in our research brief, where you’ll learn how to position your own program as a center of excellence by pursuing multidisciplinary care and appealing to referring providers.
Download the research brief
Profiles of six U.S. melanoma programs
These innovative programs are transforming care by developing extensive clinical research capabilities, early detection strategies, and more. Read each profile to learn about their plans for growth and the program-specific challenges that they face.
1. University of Pittsburgh Cancer Institute
More than 30 years old, the University of Pittsburgh’s melanoma program is a leader in targeted anti-tumor and immunologic treatment innovation.
2. Indiana University Health
Indiana University Health’s melanoma program specializes in in-depth coordinated care and hosts a weekly multidisciplinary conference that reviews all advanced melanoma cases.
Use our melanoma program resource grid
to benchmark your offerings and prioritize areas of investment.
3. Providence Health and Services Providence Cancer Center
Providence Health and Services' melanoma program supports expansive clinical research. The cancer program's overall clinical trial accrual rate doubled in the first half of 2015—largely due to melanoma.
4. Seattle Cancer Care Alliance
Seattle Cancer Care Alliance's melanoma program is pioneering improved patient access and more effective initial consultations through the "Now Clinic."
5. Oregon Health & Science University Knight Cancer Institute
The OHSU Knight Cancer Institute runs a lauded early detection program that focuses on raising public awareness through community education and the unique Melanoma Community Registry.
6. Inova Schar Cancer Institute
At the Inova Schar Cancer Institute, weekly skin screening clinics see about 100 patients a month and forward confirmed melanoma cases to a prospective multidisciplinary planning conference.
Key considerations for investment
Increasing volumes, growing competition, expanding treatment options, and higher clinical research standards are just a handful of the many developments that cancer programs must consider before investing in advanced melanoma centers. Is your organization ready? Learn more.
Technology profile: Total Body Photography Systems
Get a breakdown of one of the technologies changing melanoma care—Total Body Photography Systems (TBPS). Learn why TBPS is making melanoma centers stand out in a competitive market, what you need to adopt TBPS capabilities, and how Medicare reimburses TBPS use. Learn more.
Next, Check Out
Tumor Site Centers of Excellence